- Home
- EQH vs VANI Comparison
EQH vs VANI Comparison
Compare EQH & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQH
- VANI
- Stock Information
- Founded
- EQH 1859
- VANI 1998
- Country
- EQH United States
- VANI United States
- Employees
- EQH N/A
- VANI N/A
- Industry
- EQH Specialty Insurers
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EQH Finance
- VANI Health Care
- Exchange
- EQH Nasdaq
- VANI Nasdaq
- Market Cap
- EQH 16.2B
- VANI 75.8M
- IPO Year
- EQH N/A
- VANI 2014
- Fundamental
- Price
- EQH $53.54
- VANI $1.45
- Analyst Decision
- EQH Buy
- VANI Strong Buy
- Analyst Count
- EQH 11
- VANI 1
- Target Price
- EQH $64.55
- VANI $4.00
- AVG Volume (30 Days)
- EQH 2.6M
- VANI 116.3K
- Earning Date
- EQH 11-03-2025
- VANI 11-12-2025
- Dividend Yield
- EQH 2.05%
- VANI N/A
- EPS Growth
- EQH N/A
- VANI N/A
- EPS
- EQH 1.38
- VANI N/A
- Revenue
- EQH $13,960,000,000.00
- VANI N/A
- Revenue This Year
- EQH $17.36
- VANI N/A
- Revenue Next Year
- EQH $1.25
- VANI N/A
- P/E Ratio
- EQH $38.27
- VANI N/A
- Revenue Growth
- EQH 21.29
- VANI N/A
- 52 Week Low
- EQH $40.81
- VANI $0.91
- 52 Week High
- EQH $56.61
- VANI $1.80
- Technical
- Relative Strength Index (RSI)
- EQH 52.46
- VANI 62.65
- Support Level
- EQH $52.52
- VANI $1.19
- Resistance Level
- EQH $54.43
- VANI $1.33
- Average True Range (ATR)
- EQH 1.17
- VANI 0.10
- MACD
- EQH -0.01
- VANI 0.02
- Stochastic Oscillator
- EQH 64.98
- VANI 75.61
About EQH Equitable Holdings Inc.
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.